Benefit- risk profilen af Lansoprazol HEXAL 15 mg, 30 mg til de ansøgte indikationer kan derfor anses for gunstig.
Therefore, the benefit-risk profile of Lansoprazol HEXAL 15 mg, 30 mg in the proposed indications can be considered favourable.